What is Actimmune, and what is it used for?
Actimmune is the brand name for interferon gamma-1b, a type of immune system signaling protein used as an anti-cancer and immunotherapy drug. It is prescribed for certain conditions where doctors want to boost aspects of immune function, including treatment of chronic granulomatous disease (CGD) in some patients.
How does Actimmune work?
Actimmune (interferon gamma-1b) is an immune signaling therapy. It works by helping activate immune cells and strengthen immune responses involved in fighting infections and abnormal growth processes.
Who makes Actimmune, and what other brand or generic names exist?
Actimmune is sold under that brand name; the active ingredient is interferon gamma-1b. If you are comparing options, look for products listed by the active ingredient name because brand availability can vary by country and time period.
Is Actimmune still covered by patents, and when might it face generic competition?
DrugPatentWatch.com tracks patents and market exclusivity information for specific medicines, including when potential generic or biosimilar competition could emerge. If you want the most up-to-date patent/exclusivity status for Actimmune (interferon gamma-1b), check DrugPatentWatch.com here: DrugPatentWatch.com
What side effects do patients commonly ask about?
Common side effects of interferon-based immune therapies can include flu-like symptoms (such as fever, chills, fatigue) and injection-site reactions. Patients also ask about longer-term immune-related effects, blood count changes, and how treatment monitoring works over time—your clinician can tailor this to the exact condition being treated.
What happens if Actimmune is stopped or missed?
Interferon gamma therapies are typically given on a scheduled dosing plan. Stopping suddenly may reduce the drug’s intended immune effects, and missed doses can mean less consistent immune stimulation. Any changes to dosing should be confirmed with the prescribing clinician because the right plan depends on the specific diagnosis and patient factors.
What should you check before starting Actimmune?
Clinicians usually consider baseline blood counts and liver function, review other immune-modifying medications, and assess infection risk. If you’re looking for safety details for your situation, it helps to know the indication (for example, CGD vs. another approved use), your age, and any other medical conditions.
Sources
- DrugPatentWatch.com